The Digital Source For China's Tech Innovation Since 2000

Search
Close

New Pfizer Clinical Trial Center For Shanghai

November 5, 2003
Science

Pfizer, the pharmaceutical company, will soon set up a regional headquarters and its first clinical trial center in the city, which already has some of the best medical talent and medical science resources in the country.

Allan Gabor, chairman and general manager of Pfizer Pharmaceuticals Ltd China, recently said: "The legal procedures for setting up the regional headquarters are now under way and the Shanghai-based clinical trial center project is an indication of our confidence in China."

Pfizer acquired Shanghai-based Pharmacia in April this year, which has one holding company and three factories in China, greatly accelerating Pfizer's new business in China, and thus requiring the setting up of a regional headquarters to facilitate better national management. At present, Pfizer offers 40 innovative products in China and another 13 new drugs are planned to be introduced to Chinese consumers within five years, hence the need to build a center in Shanghai.

"China's clinical trial center will not only be concerned developing drugs for local approval, but also be part of Pfizer's global R&D (research and development) network," said Gobar. Clinical trial is the last phase in the development of new drugs, and Chinese medical institutes are becoming increasingly aware that active participation in international clinical trials is essential to success in the industry.

Aside from Pfizer, a number of other multinational pharmaceutical companies have expressed their willingness to develop R&D centers in the city. The Shanghai branch of Swiss-based Roche will present a proposal for setting up a R&D centre in China to its headquarters in Switzerland within four to six weeks. In early October, US-based Eli Lilly declared operational its China research lab in the Zhangjiang Hi-Tech Park, built in co-operation with its Chinese partner Shanghai ChemExplorer, a chemical research company.

Tags: Business | chairman | China | Chinese | development | drugs | Eli Lilly | general manager | headquarters | international | lab | legal | management | medical | network | pharmaceutical | R&D | research | research and development | Science | Shanghai | Switzerland | talent | technology | Three

Other Related News:

Alibaba, Ant Financial Enhanced Strategic Cooperation With ICBC

December 16, 2019

Shanda Literature Cuts China E-book Staff

July 29, 2013

China Mobile Promises To Save 11.8 Billion Kilowatts Over Next Three Years

November 12, 2009

Chinese Anti-America Internet Celebrity Arrested for Running P2P Lending Platform

August 1, 2021

Mobile cabin COVID-19 hospitals supported by mainland being constructed in Hong Kong

February 23, 2022

VLC media player is reportedly under Chinese malware threat TechiLive.in

April 10, 2022

Hong Kong media group Next Digital says it aims to wind down, board quits

September 6, 2021

Xiaomi Announced To Enter Japanese Market In December 2019

December 2, 2019

The opening of the fifth session of the 12th Provincial Committee of the Chinese People’s Political Consultative Conference Peng Qinghua delivered a speech, Huang Qiang, Wang Qiang and others attended the meeting to congratulate Ke Zunping on his work report_Sichuan Online

January 17, 2022
  • Contact Us
  • About Us
  • Corrections and Disclosure
  • Privacy Policy
  • Terms & Conditions
Menu
  • Contact Us
  • About Us
  • Corrections and Disclosure
  • Privacy Policy
  • Terms & Conditions
© 2022 ChinaTechNews.com. A Service of Asia Media Network.
Twitter
Posting....